Fatty Liver Disease and Multi-System Complications | EK28

Mar 21, 2021 ‐ Mar 23, 2021


Sessions

[Joint Session] Welcoming Remarks and Keynote Session icon[Joint Session] Welcoming Remarks and Keynote Session

Preview Available

[Joint Session] Welcoming Remarks and Keynote Session

Mar 22, 2021 9:00am ‐ Mar 22, 2021 10:10am

Co-Chair(s):
Changing Epidemiological Trends in Non-Alcoholic Fatty Liver Disease versus Viral-Associated Hepatobiliary Cancers iconChanging Epidemiological Trends in Non-Alcoholic Fatty Liver Disease versus Viral-Associated Hepatobiliary Cancers

Preview Available

Changing Epidemiological Trends in Non-Alcoholic Fatty Liver Disease versus Viral-Associated Hepatobiliary Cancers

Mar 22, 2021 9:35am ‐ Mar 22, 2021 10:10am

Speaker(s):
[Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers icon[Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers

Preview Available

[Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers

Mar 22, 2021 10:10am ‐ Mar 22, 2021 12:00pm

Co-Chair(s):
A TGF-ß-ALDH2 Axis in Obesity, Metabolic Syndrome, and HCC iconA TGF-ß-ALDH2 Axis in Obesity, Metabolic Syndrome, and HCC

Preview Available

A TGF-ß-ALDH2 Axis in Obesity, Metabolic Syndrome, and HCC

Mar 22, 2021 10:10am ‐ Mar 22, 2021 10:35am

Speaker(s):
Coffee Break iconCoffee Break

Preview Available

Coffee Break

Mar 22, 2021 10:35am ‐ Mar 22, 2021 10:55am

The Gut-Liver Axis in Liver Cancer Risk Conditions iconThe Gut-Liver Axis in Liver Cancer Risk Conditions

Preview Available

The Gut-Liver Axis in Liver Cancer Risk Conditions

Mar 22, 2021 10:55am ‐ Mar 22, 2021 11:20am

Speaker(s):
Lipid Dysregulation in Inflammation, NASH, and Cancer iconLipid Dysregulation in Inflammation, NASH, and Cancer

Preview Available

Lipid Dysregulation in Inflammation, NASH, and Cancer

Mar 22, 2021 11:20am ‐ Mar 22, 2021 11:45am

Speaker(s):
Short Talk: The α1-Na/K-ATPase/Src-p/PI3K Pathway Modulates the Survivin-SMAC Apoptotic “Switch” in NASH Related Hepatocellular Carcinoma: A Translational Study iconShort Talk: The α1-Na/K-ATPase/Src-p/PI3K Pathway Modulates the Survivin-SMAC Apoptotic “Switch” in NASH Related Hepatocellular Carcinoma: A Translational Study

Preview Available

Short Talk: The α1-Na/K-ATPase/Src-p/PI3K Pathway Modulates the Survivin-SMAC Apoptotic “Switch” in NASH Related Hepatocellular Carcinoma: A Translational Study

Mar 22, 2021 11:45am ‐ Mar 22, 2021 12:00pm

Speaker(s):
[Joint Session] Career Roundtable icon[Joint Session] Career Roundtable

Preview Available

[Joint Session] Career Roundtable

Mar 22, 2021 1:30pm ‐ Mar 22, 2021 2:30pm

Panelist(s):
[Joint Session] Live Poster Session Day 1 icon[Joint Session] Live Poster Session Day 1

Preview Available

[Joint Session] Live Poster Session Day 1

Mar 22, 2021 3:00pm ‐ Mar 22, 2021 4:00pm